C-suite leaders need to be aware of trends in the present that are likely to become our future reality. #WEF neatly describes the future as “both a realm of study and a landscape to shape”; as we study it in detail, and WEF notes the advancements across 10 emerging technologies for 2024, three in particular caught my eye. Not only am I following these closely myself for HotTopics, but they each have burning questions that may impact their potency for genuine change. 1. AI for scientific discovery Deep Mind’s #AlphaFold is accurately predicting 3D models of protein structures, and researchers are discovering a new family of antibiotics, as well as materials for more efficient batteries. We are seeing similar advances in the diagnosis, treatment and prevention of diseases, and in how the human mind is understood. More research is needed to manage AIs impact. Beyond energy usage and ethics, tackling inherent biases in data sets and improving the reliability of model-generated content is crucial to scientific integrity. Look out for: intellectual property rights, particularly ownership and copyright of model-generated content, are still largely unaddressed. 2. Privacy-enhancing technologies Access to increasingly large datasets powers genAI, and transforms research, discovery and innovation. However, appropriate concerns around privacy, security and data sovereignty limit the degree to which high-value data can be shared and used. CISOs and CROs are renewing interest in homomorphic encryption, which allows encoded data to be analysed without the raw data being directly accessible. It does, however, require significantly more energy and time to achieve a secure result. I’m also hearing a lot about synthetic data. Powered by AI, synthetic data “removes many of the restrictions to working with sensitive data and opens new possibilities in global data sharing.” Look out for: Regulation on synthetic data is a grey area, and certain data sets (like, national health) are too vulnerable to be considered in this context—yet. 3. Reconfigurable intelligent surfaces Global demand for higher data rates, lower latency and energy-efficient connectivity is skyrocketing; the launch of 6G by 2030 will compound this demand. Enter: reconfigurable intelligent surfaces (#RIS). RIS platforms use meta-materials, smart algorithms and advanced signal processing to turn ordinary walls and surfaces into “intelligent components for wireless communication.” The growth of RIS is likely to impact several industrial sectors: tailored radio wave propagation in smart factories can ensure reliable communication in a highly complex environment; or, to improve coverage in farming, RIS has low energy consumption and high-cost efficiency. Look out for: Hardware costs need reducing immediately, as is the need for clearer standards and regulations on the secure and ethical use of the technology. https://lnkd.in/gZ94_MUM
Research and Development Trends
Explore top LinkedIn content from expert professionals.
Summary
Research-and-development-trends refer to the evolving patterns, priorities, and innovations shaping how companies and industries invest in scientific discovery and new technology. These trends impact sectors ranging from medicine and biotechnology to engineering and digital services, driving progress and influencing global collaboration.
- Watch global shifts: Stay aware of changing research partnerships and government initiatives, as they can alter funding opportunities and innovation pipelines.
- Adopt emerging tech: Explore new technologies like AI, quantum computing, and privacy tools to stay competitive and address industry-specific challenges.
- Build skilled teams: Invest in recruiting and training talent in critical areas such as biotechnology, data science, and digital health to keep pace with current R&D demands.
-
-
Global dynamics in science are shifting. The U.S. recently paused new NIH grants to international research partners — a decision that has disrupted collaborations across Canada, Europe, and beyond. While the reasons are complex, the result is clear: scientific partnerships are being redefined. Meanwhile, the EU is moving to position itself as a leader in global research. This week, Ursula von der Leyen announced Choose Europe for Science — a €500M initiative to support young researchers, strengthen academic freedom, and attract global talent. Just weeks earlier, CEOs from 32 leading pharma companies including Pfizer, Novartis, GSK, and Sanofi urged the European Commission to ensure faster approvals, stronger IP protection, and support for AI-driven R&D. Without those, they warned, Europe could risk losing up to €100B in investment by 2029. These developments highlight a global inflection point in life sciences: 🔹 The U.S. remains a powerful hub for innovation — but is revisiting the scope of its international engagement. 🔹 Europe is investing in talent and infrastructure — but still faces challenges in regulatory agility and tech adoption. Big initiatives make headlines. But it's predictable regulation, sustained investment, and infrastructure that supports AI-driven science that truly build innovation ecosystems. #biotech #drugdiscovery #lifesciences #sciencepolicy #EU #US #researchfunding #AIinScience #innovation
-
Have you ever wondered how R&D investments translate into revenue across different industries? And when spending more on R&D can translate to worse results? I recently analyzed data from 2017 to 2024 from a series of EU Industrial R&D Investment Scoreboard files on four major sectors (figures are thus in Euros): Industry-Specific Growth Patterns (2017-2024) Electronics & Electrical Equipment: Most consistent revenue growth pattern Net sales grew from ~1200M€ to ~2500M€ (>100% increase) R&D growth rates relatively stable (5-15% range) Shows resilience Pharma & Biotech: Highest R&D growth volatility (spikes to 28% in 2022 in the wake of the pandemic) Lowest median net sales (~200-300M€) but highest R&D intensity Dramatic R&D growth spike (2021-2022) as the pandemic drug development engine revved up Post-2022 normalization in R&D growth rates Inflection Points 2020 (Pandemic Impact): All sectors maintained positive R&D growth despite crisis Tech Hardware showed most resilience (smallest growth rate change) Pharma maintained sales stability while others fluctuated 2022 (Peak Investment): Record R&D growth across all sectors Pharma/Biotech led with ~28% growth Software/Computer Services followed at ~22% Suggests broad-based innovation push Inverse relationships: Electronics: Highest revenue (~2500M€) but moderate R&D growth Pharma: Lowest revenue but highest R&D growth spikes Software: Mid-range revenue but consistently high R&D growth
-
As we close 2024, below are some key technology trends expected to shape 2025. These trends highlight a blend of cutting-edge technologies driving innovation across industries while addressing sustainability and societal challenges. 1. Artificial Intelligence (AI) Advancements ⚡️Generative AI: Continued growth in generative AI models (like GPT-4, MidJourney, or DALL-E), with more sophisticated content generation for text, images, and video. ⚡️AI in Industries: AI adoption in healthcare, education, finance, and customer service to optimize workflows, automate processes, and make predictions. ⚡️Explainable AI (XAI): Increasing focus on transparency and accountability in AI decision-making. 2. Quantum Computing ⚡️Advances in quantum hardware and algorithms, bringing quantum computing closer to solving real-world problems like cryptography, pharmaceuticals, and complex simulations. 3. 5G and the Path to 6G ⚡️Widespread implementation of 5G networks enabling faster, low-latency connectivity. ⚡️Early research and experimentation for 6G networks to achieve even faster speeds and support advanced IoT and AI applications. 4. Immersive Technologies (AR, VR, and XR) ⚡️Enhanced AR (Augmented Reality) integration in mobile devices and enterprise solutions. ⚡️Lighter, more affordable AR/VR hardware enabling mainstream adoption. 5. Robotics and Automation ⚡️Increased use of robotics for precision work in manufacturing, healthcare (surgery robots), agriculture, and logistics. ⚡️Growth in humanoid robots and AI-driven automation tools for businesses. 6. Sustainable and Green Technologies ⚡️Energy-efficient data centers and green AI practices to reduce computing's environmental impact. ⚡️Advancements in renewable energy technologies like solar, wind, and battery storage. ⚡️Focus on circular economy systems, including recycling and sustainable materials. 7. Cybersecurity Evolution ⚡️Rise in AI-driven cybersecurity tools to combat sophisticated cyber threats. ⚡️Increasing importance of zero-trust architecture for enhanced protection. 8. Edge Computing ⚡️Growth in edge computing to process data closer to the source, enabling faster real-time processing for IoT and AI applications. ⚡️Integration with 5G and cloud services for more efficient networks. 9. Biotechnology and Health Tech ⚡️Advances in CRISPR gene editing for medical treatments and agriculture. ⚡️Increased deployment of AI-powered diagnostics and precision medicine. ⚡️Growth of wearable health tech for real-time monitoring and personalized healthcare. 10. Autonomous Systems ⚡️Continued advancements in autonomous vehicles (cars, trucks, and drones). ⚡️Smart cities integrating autonomous infrastructure for public transportation and deliveries. 11. Human-AI Collaboration ⚡️Enhanced tools for human-AI collaboration (AI copilots) in creative, technical, and decision-making tasks. ⚡️AI-enhanced education platforms offering personalized learning experiences. #ai #Immersive #ar #vr #techtrends
-
Pharmaceutical and healthtech firms in India are rapidly expanding their research and development (R&D) teams, Brinda Sarkar and Sreeradha Basu report for The Economic Times. Reasons? To boost innovation, meet strict regulatory norms, enhance growth areas, and deliver high-quality products across different therapeutic areas. The trend is driven by growing interest from private equity players to invest in pharma and healthtech firms. Sudhir Kesavan, COO of CitiusTech, says that the healthcare sector is changing rapidly, and the adoption of digital technologies and agentic AI is opening up new possibilities for improving patient experience, clinical outcomes, and therapy research. R&D activity is increasing in segments such as AI and machine learning in diagnostics, predictive analytics, digital therapeutics, remote monitoring, personalised care and health platforms, the report says. Nupur Mehta, Partner at Page Executive, says, “We’re seeing an uptick in Indian firms, along with multinational corporations, prioritising the expansion of their R&D teams, particularly by setting up global capability centres (GCCs) and research hubs within India.” Institutions like the IISc, IITs, NIPERs, and foreign universities, which are known for life sciences, bioengineering, and medical research, are hotspots for R&D hires, adds the report. Source: The Economic Times - https://lnkd.in/g3v8DdGg ✍ : Novinston Lobo 📸 : Getty Images #Pharmaceutical #HealthTech #PharmaR&D #MedicalResearch
-
I foresee a notable shift in the global distribution of R&D towards India within the next decade. India's expansive and expanding community of scientists, engineers, and technical professionals, coupled with cost advantages compared to developed nations, alongside proactive government support for R&D initiatives and funding, will drive this trend. However, there are key areas that I believe warrant prioritization: 1. Infrastructure Development: India's talent pool is robust, yet there remains a need for improvements in research infrastructure in certain sectors. 2. University-Industry Collaboration: Strengthening connections between universities and industries can foster greater innovation and mutual benefit. 3. Intellectual Property (IP) Regime: A robust IP system is pivotal in attracting foreign companies and encouraging domestic R&D efforts.